Literature DB >> 1234325

The dopamine hypothesis of schizophrenia. A critical analysis.

D Luchins.   

Abstract

The evidence linking dopamine and schizophrenia is reviewed. Surveyed are studies on dopamine metabolites in schizophrenia, the effects of dopamine agonists, antagonists and depletors on schizophrenia and the action of present treatments of schizophrenia on dopamine. As well, the interrelationship of dopaminergic, cholinergic and gabanergic pathways is examined. It is concluded that the relationship between dopaminergic mechanisms and schizophrenia is nonspecific. The dopamine hypothesis is shown to reflect an attitude towards schizophrenia that emphasizes acute, florid symptoms. It is suggested that researche directed towards studying dopaminergic mechanisms in specific psychopathological symtoms, not syndromes, might prove fruitful.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234325     DOI: 10.1159/000117513

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  3 in total

Review 1.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

Review 2.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions.

Authors:  Roudabeh Vakil Monfared; Wedad Alhassen; Tri Minh Truong; Michael Angelo Maglalang Gonzales; Vincent Vachirakorntong; Siwei Chen; Pierre Baldi; Olivier Civelli; Amal Alachkar
Journal:  Cells       Date:  2021-10-31       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.